ARYA IV is a special purpose acquisition company sponsored by an affiliate of Perceptive Advisors, LLC. The company is focused on partnering with innovative ablation technologies for the treatment of ventricular tachycardia and other cardiac arrhythmias, aiming to create deep and durable cardiac lesions resulting in enhanced effectiveness and outcomes.